162 related articles for article (PubMed ID: 16082247)
21. Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.
Heerema-McKenney A; Wijnaendts LC; Pulliam JF; Lopez-Terrada D; McKenney JK; Zhu S; Montgomery K; Mitchell J; Marinelli RJ; Hart AA; van de Rijn M; Linn SC
Am J Surg Pathol; 2008 Oct; 32(10):1513-22. PubMed ID: 18708938
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibodies to the myogenic regulatory protein MyoD1: epitope mapping and diagnostic utility.
Dias P; Parham DM; Shapiro DN; Tapscott SJ; Houghton PJ
Cancer Res; 1992 Dec; 52(23):6431-9. PubMed ID: 1384962
[TBL] [Abstract][Full Text] [Related]
23. Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues.
Kumar S; Perlman E; Harris CA; Raffeld M; Tsokos M
Mod Pathol; 2000 Sep; 13(9):988-93. PubMed ID: 11007039
[TBL] [Abstract][Full Text] [Related]
24. Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation.
Tallini G; Parham DM; Dias P; Cordon-Cardo C; Houghton PJ; Rosai J
Am J Pathol; 1994 Apr; 144(4):693-701. PubMed ID: 8160771
[TBL] [Abstract][Full Text] [Related]
25. Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development.
Tonin PN; Scrable H; Shimada H; Cavenee WK
Cancer Res; 1991 Oct; 51(19):5100-6. PubMed ID: 1717137
[TBL] [Abstract][Full Text] [Related]
26. Caveolin 1 is a marker of poor differentiation in Rhabdomyosarcoma.
Rossi S; Poliani PL; Cominelli M; Bozzato A; Vescovi R; Monti E; Fanzani A
Eur J Cancer; 2011 Mar; 47(5):761-72. PubMed ID: 21106364
[TBL] [Abstract][Full Text] [Related]
27. Does alveolar soft-part sarcoma exhibit skeletal muscle differentiation? An immunocytochemical and biochemical study of myogenic regulatory protein expression.
Wang NP; Bacchi CE; Jiang JJ; McNutt MA; Gown AM
Mod Pathol; 1996 May; 9(5):496-506. PubMed ID: 8733764
[TBL] [Abstract][Full Text] [Related]
28. MURC/cavin-4 Is Co-Expressed with Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line.
Faggi F; Codenotti S; Poliani PL; Cominelli M; Chiarelli N; Colombi M; Vezzoli M; Monti E; Bono F; Tulipano G; Fiorentini C; Zanola A; Lo HP; Parton RG; Keller C; Fanzani A
PLoS One; 2015; 10(6):e0130287. PubMed ID: 26086601
[TBL] [Abstract][Full Text] [Related]
29. Retinoic acid induces myogenin synthesis and myogenic differentiation in the rat rhabdomyosarcoma cell line BA-Han-1C.
Arnold HH; Gerharz CD; Gabbert HE; Salminen A
J Cell Biol; 1992 Aug; 118(4):877-87. PubMed ID: 1323566
[TBL] [Abstract][Full Text] [Related]
30. Adult urinary bladder tumors with rhabdomyosarcomatous differentiation: clinical, pathological and immunohistochemical studies.
Bing Z; Zhang PJ
Diagn Pathol; 2011 Jul; 6():66. PubMed ID: 21762516
[TBL] [Abstract][Full Text] [Related]
31. Myogenic markers in the evaluation of embryonal botryoid rhabdomyosarcoma of the female genital tract.
Riedlinger WF; Kozakewich HP; Vargas SO
Pediatr Dev Pathol; 2005; 8(4):427-34. PubMed ID: 16220232
[TBL] [Abstract][Full Text] [Related]
32. Myogenic markers in the evaluation of embryonal botryoid rhabdomyosarcoma of the female genital tract.
Riedlinger WF; Kozakewich HP; Vargas SO
Pediatr Dev Pathol; 2005; 8(3):355-61. PubMed ID: 16010486
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of myogenic regulatory genes, MyoD1 and myogenin, in human rhabdomyosarcoma sublines.
Hosoi H; Sugimoto T; Hayashi Y; Inaba T; Horii Y; Morioka H; Fushiki S; Hamazaki M; Sawada T
Int J Cancer; 1992 Apr; 50(6):977-83. PubMed ID: 1313401
[TBL] [Abstract][Full Text] [Related]
34. Chemoradiotherapy-induced Cytodifferentiation in Bladder/Prostate Rhabdomyosarcoma With Genetic Downregulation of Myogenin and MyoD1 Gene Expression: A Case Study and Review of the Literature.
Agard H; Clark C; Massanyi E; Steele M; McMahon D
Urology; 2020 Mar; 137():173-177. PubMed ID: 31945380
[TBL] [Abstract][Full Text] [Related]
35. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
Mikami Y; Hata S; Kiyokawa T; Manabe T
Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
[TBL] [Abstract][Full Text] [Related]
36. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers.
Furlong MA; Mentzel T; Fanburg-Smith JC
Mod Pathol; 2001 Jun; 14(6):595-603. PubMed ID: 11406662
[TBL] [Abstract][Full Text] [Related]
37. Expression of cardiac ankyrin repeat protein, CARP, in malignant tumors: diagnostic use of CARP protein immunostaining in rhabdomyosarcoma.
Ishiguro N; Motoi T; Araki N; Ito H; Moriyama M; Yoshida H
Hum Pathol; 2008 Nov; 39(11):1673-9. PubMed ID: 18656235
[TBL] [Abstract][Full Text] [Related]
38. Primary osseous rhabdomyosarcoma with focal matrix formation mimicking osteosarcoma.
Kordek R; Sowa P; Panasiuk M; Kmieciak M; Chudobinski C; Pluciennik E; Bednarek AK; Potemski P; Jesionek-Kupnicka D
Pathol Res Pract; 2007; 203(12):873-7. PubMed ID: 17905523
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic evaluation of metastatic rhabdomyosarcoma in effusion specimens.
Alderman MA; Thomas DG; Roh MH
Diagn Cytopathol; 2013 Nov; 41(11):955-9. PubMed ID: 23584957
[TBL] [Abstract][Full Text] [Related]
40. Detection of the MyoD1 transcript in rhabdomyosarcoma cell lines and tumor samples by reverse transcription polymerase chain reaction.
Frascella E; Rosolen A
Am J Pathol; 1998 Feb; 152(2):577-83. PubMed ID: 9466584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
